Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT06322615
This clinical trial evaluates whether acupressure is helpful to reduce anxiety related to chemotherapy. Anxiety is experienced by many patients with cancer. Anxiety can be related to chemotherapy and may contribute to other symptoms, such as nausea and poor quality of life. Some patients diagnosed with cancer express interest in non-medicinal ways to manage symptoms. Acupressure is a noninvasive intervention that can be used for many different symptoms. Acupressure is well tolerated with minimal reports of adverse reactions, making it a good choice for patients with cancer. This study may help researchers learn whether acupressure is useful for managing anxiety in patients undergoing chemotherapy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
PRIMARY OBJECTIVES:
I. Evaluate the feasibility of a nurse- and patient-applied acupressure intervention for patients with anxiety associated with active cancer-directed therapy.
II. Patient-reported changes in acute anxiety associated with both the nurse and self-led acupressure interventions will be ascertained.
OUTLINE:
Patients undergo acupressure over 15-120 seconds at a time for up to 15 minutes. After completion of the session, patients may optionally receive an education session on using acupressure at home.
After completion of study intervention, patients who opted to receive education about using acupressure at home are followed up at 1 week.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Undergo acupressure
Other names: Acupressure, Ischemic Compression
Receive education session about using acupressure at home
Other names: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Ancillary studies
Ancillary studies
Time frame: Up to 1 year
Assessed by the number of patients approached about undergoing acupressure intervention.
Time frame: Up to 1 year
Assessed by the number of patients who express interest in the initial acupressure intervention in the chemotherapy unit.
Time frame: Up to 1 year
Assessed by the number of patients who express interest in the home acupressure intervention.
Time frame: Up to 1 year
Assess by the time recorded for ach nurse-led acupressure intervention in the chemotherapy unit.
Time frame: At baseline, after a one-time nurse-administered acupressure session, and after one week of self-administered acupressure sessions
Assessed with a brief anxiety questionnaire that inquires about the three different domains of anxiety: cognitive symptoms, emotional symptoms, and physical symptoms. Seven questions are answered using 11-point (0-10) scales with different values assigned to the scale per question (e.g. 0=no anxiety/10=worst possible anxiety or 0=strongly disagree/10=strongly agree).
Mayo Clinic
Other
Acupressure for Anxiety: A Pilot Study of a Nurse-Led Acupressure Intervention for Patients Receiving Chemotherapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03223753
Carcinoma, Carcinoma in Situ
Birmingham, Alabama, United States
View Trial DetailsNCT06442891
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Ann Arbor, Michigan, United States
View Trial DetailsNCT06602999
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
San Francisco, California, United States
View Trial DetailsNCT06484595
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Seattle, Washington, United States
View Trial Details